Journal rankings · indicator year 2019
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2019
Endocrinology, Diabetes and Metabolism journal rankings 2019
168 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 168 ranked journals in 2019. The median OJR fell 0.09 on 2018 to 0.86, below the world average of 1.00; Q1 starts at OJR 1.43. The top three are Endocrine Reviews, Diabetes Care, and The Lancet Diabetes & Endocrinology.
Ranks and citation indicators: 2019. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2016–2018, the window the 2019 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery936
- Pulmonary and Respiratory Medicine347
- Public Health, Environmental and Occupational Health299
- Cardiology and Cardiovascular Medicine290
- Oncology234
- Infectious Diseases217
- Epidemiology198
- Endocrinology, Diabetes and Metabolism168
- Neurology164
- Physiology160
- Radiology, Nuclear Medicine and Imaging153
- Psychiatry and Mental health142
Show all 42 subfields
- Orthopedics and Sports Medicine120
- Pediatrics, Perinatology and Child Health103
- Ophthalmology98
- Dermatology96
- Hematology80
- Obstetrics and Gynecology74
- Rheumatology67
- Nephrology58
- Complementary and alternative medicine54
- Pharmacology54
- Reproductive Medicine50
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology35
- Rehabilitation34
- Pathology and Forensic Medicine31
- Critical Care and Intensive Care Medicine24
- Genetics24
- Hepatology23
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology7
- Internal Medicine5
- Health Informatics4
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
168 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2018. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2016–2018, the window the 2019 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2016–2018 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2010 to 2019. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 6.83Q1 | 15.96 3.67 up from 2018 | 122 | 81% | $3,750 | ||
2Diabetes CareAmerican Diabetes Association · United States | 5.57Q1 | 13.90 1.68 up from 2018 | 1,216 | 62% | — | ||
3The Lancet Diabetes & EndocrinologyElsevier BV · Netherlands | 5.19Q1 | 13.65 2.81 up from 2018 | 525 | 45% | $7,280 | ||
4DiabetologiaSpringer Science+Business Media · Germany | 3.22Q1 | 8.25 0.68 up from 2018 | 855 | 91% | $3,490 | ||
5Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 3.12Q1 | 7.80 1.01 up from 2018 | 129 | 31% | $5,590 | ||
6The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 2.56Q1 | 5.89 0.60 down from 2018 | 1,691 | 85% | $3,750 | ||
7Journal of Internal MedicineWiley · United Kingdom | 2.54Q1 | 6.42 0.94 up from 2018 | 348 | 70% | $4,780 | ||
8European Journal of EndocrinologyOxford University Press · United Kingdom | 2.49Q1 | 6.48 0.37 up from 2018 | 547 | 40% | $4,292 | ||
9Diabetes Obesity and MetabolismWiley · United Kingdom | 2.39Q1 | 6.16no change | 901 | 55% | $5,380 | ||
10Cardiovascular DiabetologyOABioMed Central · United Kingdom | 2.33Q1 | 8.31 1.64 up from 2018 | 467 | 100% | $4,290 | ||
11Current Diabetes ReportsSpringer Science+Business Media · United States | 2.27Q1 | 4.95 0.24 down from 2018 | 410 | 38% | $4,890 | ||
12ThyroidMary Ann Liebert, Inc. · United States | 2.26Q1 | 6.31 0.07 up from 2018 | 590 | 43% | — | ||
13Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 2.14Q1 | 4.71 0.31 down from 2018 | 173 | 25% | $4,450 | ||
14Journal of DiabetesOAWiley · Australia | 2.13Q1 | 6.76 4.10 up from 2018 | 374 | 38% | $3,000 | ||
15JMIR DiabetesOACanada | 2.12Q1 | 3.48 0.51 up from 2018 | 66 | 100% | $1,873 | ||
16World Journal of DiabetesOAHong Kong SAR China | 2.12Q1 | 4.09 0.62 down from 2018 | 146 | 100% | — | ||
17Clinical Diabetes and EndocrinologyOABioMed Central · United Kingdom | 2.11Q1 | 4.58 0.38 down from 2018 | 54 | 100% | $2,290 | ||
18Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.06Q1 | 4.88 0.44 up from 2018 | 179 | 15% | $3,540 | ||
19Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 2.04Q1 | 5.93 0.79 up from 2018 | 389 | 51% | — | ||
20BMJ Open Diabetes Research & CareOABMJ · United Kingdom | 2.03Q1 | 5.04 0.88 up from 2018 | 248 | 100% | $3,000 | ||
21Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 1.97Q1 | 4.03 0.17 up from 2018 | 185 | 12% | — | ||
22Journal of EndocrinologyBioscientifica · United Kingdom | 1.91Q1 | 4.30 1.04 down from 2018 | 440 | 92% | — | ||
23Therapeutic Advances in Endocrinology and MetabolismOASAGE Publishing · United Kingdom | 1.88Q1 | 3.69 0.34 up from 2018 | 73 | 100% | $2,650 | ||
24Frontiers in EndocrinologyOAFrontiers Media · Switzerland | 1.87Q1 | 4.79 0.07 up from 2018 | 1,265 | 100% | $3,801 | ||
25Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.84Q1 | 5.57 1.36 up from 2018 | 1,043 | 28% | $4,410 | ||
26Endocrine Related CancerBioscientifica · United Kingdom | 1.77Q1 | 4.96 0.16 up from 2018 | 438 | 96% | — | ||
27PituitarySpringer Science+Business Media · Netherlands | 1.74Q1 | 4.59 0.61 up from 2018 | 211 | 29% | $4,490 | ||
28Endocrine PracticeElsevier BV · United States | 1.74Q1 | 3.64 0.95 down from 2018 | 527 | 2% | $3,480 | ||
29Pediatric DiabetesWiley · Denmark | 1.73Q1 | 4.51 1.40 up from 2018 | 405 | 84% | $2,740 | ||
30Diabetes TherapyOAAdis, Springer Healthcare · United Kingdom | 1.69Q1 | 4.53 0.93 up from 2018 | 375 | 100% | $7,400 | ||
31European Thyroid JournalOAKarger Publishers · Switzerland | 1.65Q1 | 4.25 0.50 up from 2018 | 152 | 98% | — | ||
32Diabetes Metabolic Syndrome and ObesityOADove Medical Press · New Zealand | 1.61Q1 | 3.67 0.32 down from 2018 | 194 | 100% | $2,836 | ||
33Hormone Research in PaediatricsKarger Publishers · Switzerland | 1.60Q1 | 2.45 1.48 down from 2018 | 358 | 36% | — | ||
34MaturitasElsevier BV · Netherlands | 1.53Q1 | 4.46 0.55 up from 2018 | 571 | 20% | $4,390 | ||
35Expert Review of Clinical PharmacologyTaylor & Francis · United Kingdom | 1.52Q1 | 4.26 1.11 up from 2018 | 337 | 29% | — | ||
36Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom | 1.51Q1 | 3.60 0.01 down from 2018 | 759 | 100% | $2,760 | ||
37Endocrine PathologySpringer Science+Business Media · United States | 1.49Q1 | 4.02 0.07 up from 2018 | 141 | 25% | $3,190 | ||
38EndocrinologyOxford University Press · United States | 1.48Q1 | 4.05 0.36 up from 2018 | 1,098 | 87% | $3,750 | ||
39Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.48Q1 | 4.05 0.48 up from 2018 | 443 | 25% | $3,000 | ||
40Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom | 1.46Q1 | 3.61 0.26 up from 2018 | 272 | 100% | $2,890 | ||
41Clinical EndocrinologyWiley · United Kingdom | 1.43Q1 | 3.57 0.41 up from 2018 | 690 | 38% | $4,250 | ||
42The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 1.43Q1 | 3.49 0.81 up from 2018 | 151 | 25% | $4,400 | ||
43Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.41Q2 | 3.76 0.34 up from 2018 | 750 | 100% | $2,990 | ||
44Endocrine ConnectionsOABioscientifica · United Kingdom | 1.41Q2 | 3.56 0.65 up from 2018 | 363 | 100% | $2,146 | ||
45Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.36Q2 | 3.61 0.02 down from 2018 | 315 | 33% | $4,780 | ||
46Journal of the Endocrine SocietyOAEndocrine Society · United States | 1.34Q2 | 3.27 0.90 up from 2018 | 309 | 100% | $3,255 | ||
47The Review of Diabetic StudiesOAGermany | 1.33Q2 | 2.05 0.12 down from 2018 | 46 | 100% | — | ||
48Journal of Diabetes InvestigationOAAsian Association for the Study of Diabetes · Australia | 1.32Q2 | 3.21 0.31 up from 2018 | 489 | 100% | $3,850 | ||
49Clinical TherapeuticsElsevier BV · United States | 1.31Q2 | 3.17 0.31 up from 2018 | 675 | 41% | $4,240 | ||
50Clinical Pharmacology Advances and ApplicationsOADove Medical Press · New Zealand | 1.31Q2 | 2.53 0.66 down from 2018 | 56 | 100% | $2,320 |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery936
- Pulmonary and Respiratory Medicine347
- Public Health, Environmental and Occupational Health299
- Cardiology and Cardiovascular Medicine290
- Oncology234
- Infectious Diseases217
- Epidemiology198
- Endocrinology, Diabetes and Metabolism168
- Neurology164
- Physiology160
- Radiology, Nuclear Medicine and Imaging153
- Psychiatry and Mental health142
- Orthopedics and Sports Medicine120
- Pediatrics, Perinatology and Child Health103
- Ophthalmology98
- Dermatology96
- Hematology80
- Obstetrics and Gynecology74
- Rheumatology67
- Nephrology58
- Complementary and alternative medicine54
- Pharmacology54
- Reproductive Medicine50
- Emergency Medicine44
- Geriatrics and Gerontology38
- Otorhinolaryngology35
- Rehabilitation34
- Pathology and Forensic Medicine31
- Critical Care and Intensive Care Medicine24
- Genetics24
- Hepatology23
- Immunology and Allergy22
- Urology14
- Anesthesiology and Pain Medicine13
- Gastroenterology7
- Internal Medicine5
- Health Informatics4
- Family Practice3
- Transplantation3
- Biochemistry1
- Anatomy0
- Microbiology0
Journals
Citations made in 2019. Corpus-wide, 83.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
53 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2016–2018, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2019. Publication window: 2016–2018. How these summaries are calculated
- Ranked journals
- 168
- Window papers (baseline)
- 70,385 +9.3% from indicator year 2016
- Median OJR
- 0.86 -9.1% from indicator year 2016
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2016–2018 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.